From the clinic to the capital markets, here is Psychedelic Invest's roundup of the key headlines for the week of January 19–25, 2026.
State of New Jersey (policy): N.J. Gov. Murphy signs $6M hospital-based psilocybin therapy pilot into law
Outgoing Governor Phil Murphy signed legislation establishing a state-run, hospital-based psilocybin research and therapy pilot program, appropriating $6 million split across three New Jersey hospitals (north, central and south). The bill also creates an 11-member Psychedelic Therapy and Research Advisory Board to oversee the two-year program, with trials designed to align with FDA study protocols. The signing added New Jersey to a growing list of states building regulated psilocybin access pathways ahead of any federal approval.
Source: prweb.com
That's the recap. Follow the Psychedelic Invest Index for how the sector is trading, and check back next week for the next edition.